J&J cutting 900 positions, mostly in sales – Diversified healthcare company Johnson & Johnson said on Thursday it was eliminating 900 positions from its Ortho-McNeil-Janssen Pharmaceutical unit in the latest downsizing move in the drug industry. The reductions occurred across Ortho-McNeil-Janssen, but the majority of the jobs impacted were from sales, spokeswoman Kara Russell said.
More big-name hospital systems limiting drug industry ties – Just a few days after Johns Hopkins announced a stricter conflict-of-interest policy for its doctors, some big-name Massachusetts hospitals are moving in a similar direction. Doctors at Partners HealthCare, a system that includes Harvard-affiliated Mass General and Brigham and Women’s hospitals as well as outpatient clinics, will be barred from accepting free meals from drug makers. They will also be prohibited from serving on drug-company “speakers’ bureaus,” where doctors are paid to give talks to other doctors.
BMS, Biogen CEOs – no rush to be acquired, thank you very much.
PLUS – Priming the Discussion: your input sought on an upcoming session on Pharma Social Media and Business Opportunities.
Subscribe to the Impactiviti blog via e-mail
Subscribe to the Impactiviti blog via RSS
Connect with Steve Woodruff